- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | POP Health appoints Stephanie O'Hagan as Senior Director | ||
| Do | Veradermics' oral treatment for female pattern hair loss delivers positive study results | ||
| Mi | Biogen and Eisai's Leqembi study shows nearly 83% of early Alzheimer's patients remained stable or improved | ||
| Mi | Alzheimer's groups call for urgent global focus on women's brain health | ||
| Di | Cherry appoints Peter Henshaw as new Managing Director | ||
| Di | AstraZeneca agrees on $1.5bn deal with Dizal Pharmaceutical | ||
| Mo | Bristol Myers Squibb's New Drug Application for mezigdomide accepted by FDA | ||
| Mo | Exonate appoints Olav Hellebø as CEO | ||
| 10.07. | Boehringer Ingelheim's Jascayd approved by MHRA for idiopathic pulmonary fibrosis | ||
| 10.07. | Ipsen to acquire Memo Therapeutics in deal worth more than €700m | ||
| 09.07. | Medical-Commercial alignment in rare disease launches: what breaks first? | ||
| 09.07. | Teva submits FDA application for paediatric Tourette syndrome therapy | ||
| 08.07. | Vertex to acquire Crinetics in deal worth around $10.0bn | ||
| 08.07. | The UK's life sciences' crossroads: competing in a market defined by speed, scale and investment | ||
| 07.07. | Novartis to acquire Myricx Bio in deal worth $1.5bn | ||
| 07.07. | Launching into an AI-powered future: a prescription for success | ||
| 06.07. | Klick Health acquires Oxford PharmaGenesis | ||
| 06.07. | ASCO 2026: the art of translation | ||
| 03.07. | Communiqué Awards 2026: Healthcare Communiquétor Neil Flash | ||
| 03.07. | Communiqué Awards 2026: celebrating excellence in healthcare communications | ||
| 02.07. | Sanofi announces phase 3 study data for infantile-onset Pompe disease | ||
| 02.07. | The outcomes economy: where next for pharma? | ||
| 01.07. | Zymeworks to acquire Theravance Biopharma in deal worth $929m | ||
| 01.07. | Achieving launch excellence through cross-functional collaboration | ||
| 30.06. | Roche's Enspryng given FDA Priority Review as thyroid eye disease treatment |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.